Detalhe da pesquisa
1.
Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials.
Basic Res Cardiol
; 112(1): 3, 2017 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27882430
2.
A Phase II study of autologous mesenchymal stromal cells and c-kit positive cardiac cells, alone or in combination, in patients with ischaemic heart failure: the CCTRN CONCERT-HF trial.
Eur J Heart Fail
; 23(4): 661-674, 2021 04.
Artigo
Inglês
| MEDLINE | ID: mdl-33811444
3.
Allogeneic Mesenchymal Cell Therapy in Anthracycline-Induced Cardiomyopathy Heart Failure Patients: The CCTRN SENECA Trial.
JACC CardioOncol
; 2(4): 581-595, 2020 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-33403362